Fabtech Technologies Ltd. Stock Analysis FABTECH.NS

Fabtech Technologies Ltd. provides complete engineering solutions for pharmaceutical, biotech, and healthcare companies. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2025-10-07. The company offers end-to-end solutions across the pharmaceutical, biotechnology, and healthcare sectors. The firm focuses on bio clean air, clean water, and process requirements, delivering solutions that span the entire project lifecycle for its customers. The company covers various dosage forms, including liquids, solids, and semisolids, across the pharmaceutical value chain. Its turnkey engineering services encompass market analysis, disease profiling, custom equipment design, and the application of advanced technologies to project execution. Its expertise spans across executing a diverse array of projects and solutions, including granulation solutions, isolator containment systems, injectable projects, encapsulation solutions, cleanroom infrastructure, cleanroom systems, cleanroom equipment, heating, ventilation, and air conditioning systems, mechanical, electrical and plumbing and packaging lines.